Kusajili – Clinical trials directory

Result of your search per sponsor: LAURENT SEBBAG, MD

Woman and Man Max 99 years
LAURENT SEBBAG, MD Update Il y a 4 ans

CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial Heart transplant is a recognized therapeutic strategy in refractory heart failure. Its success is however hampered by severe cancer occurrence and recurrence. The new m-tor inhibiting drug...

Country France
organs None
Specialty None

unknown

More information